Zoetis Inc. (NYSE:ZTS) Shares Sold by Bard Financial Services Inc.

Bard Financial Services Inc. lessened its holdings in Zoetis Inc. (NYSE:ZTS) by 54.6% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,100 shares of the company’s stock after selling 1,325 shares during the period. Bard Financial Services Inc.’s holdings in Zoetis were worth $215,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ZTS. Exencial Wealth Advisors LLC boosted its stake in shares of Zoetis by 8.9% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,130 shares of the company’s stock worth $618,000 after buying an additional 257 shares during the period. Morningstar Investment Services LLC purchased a new stake in shares of Zoetis during the fourth quarter worth approximately $332,000. Prudential PLC lifted its holdings in shares of Zoetis by 1.1% during the fourth quarter. Prudential PLC now owns 33,260 shares of the company’s stock worth $6,565,000 after purchasing an additional 377 shares during the period. Waterloo Capital L.P. purchased a new position in Zoetis in the 4th quarter valued at $504,000. Finally, Westwood Holdings Group Inc. raised its position in Zoetis by 0.7% during the 4th quarter. Westwood Holdings Group Inc. now owns 157,471 shares of the company’s stock worth $31,080,000 after buying an additional 1,070 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ZTS. Piper Sandler boosted their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Stifel Nicolaus raised their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Finally, BTIG Research upped their price target on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Nine research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Zoetis has an average rating of “Buy” and a consensus target price of $220.38.

Zoetis Stock Down 0.5 %

Shares of ZTS traded down $0.96 during midday trading on Friday, reaching $190.03. 1,697,760 shares of the company were exchanged, compared to its average volume of 2,576,563. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92. The company has a market cap of $86.71 billion, a price-to-earnings ratio of 36.61, a P/E/G ratio of 2.95 and a beta of 0.89. The stock has a 50-day moving average price of $187.30 and a 200-day moving average price of $175.47.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.31 billion. During the same quarter last year, the firm posted $1.41 earnings per share. The business’s quarterly revenue was up 8.3% on a year-over-year basis. Research analysts expect that Zoetis Inc. will post 5.84 earnings per share for the current year.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.